lunes, 17 de abril de 2017

Childhood Liver Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Childhood Liver Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

National Cancer Institute

Childhood Liver Cancer Treatment (PDQ®)–Health Professional Version

SECTIONS



Changes to This Summary (04/14/2017)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text to state that a multivariate analysis of prognostic factors has been published to help develop a new risk group classification for hepatoblastoma; this classification was used to generate a risk stratification schema to be used in international clinical trials (cited Meyers et al. as reference 37).
Added text about the results of a Children's Oncology Group study that included 30 children with metastatic hepatoblastoma who were treated with vincristine and irinotecan before standard cisplatin-based therapy (cited Katzenstein et al. as reference 85).
Added text to state that percutaneous ablation techniques may also be considered as treatment options for recurrent or progressive hepatoblastoma (cited Liu et al. as reference 95).
Added Nonviral liver injury as a new subsection.
Added text about a report from the Childhood Cancer Database that included 103 children with UESL diagnosed between 1998 and 2012 (cited Shi et al. as reference 18).
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
  • Updated: April 14, 2017

No hay comentarios:

Publicar un comentario